Tag Archives: Novartis

The transaction underpins Novartis’s strategy of achieving sustainable and profitable growth in the US in the long term. Swiss pharmaceutical company Novartis announced the divestment of its dermatology and generic tablet portfolios of Sandoz US to India’s Aurobindo Pharma for a $900 million (CHF870 million) cash payment. A possible performance-related payment of $100 million could be added to the purchase price, the...

Novartis admitted that it had signed a one-year contract with the company of Trump’s private lawyer, Michael Cohen. (Keystone) The Office of the Attorney General of Switzerland (OAG) announced on Wednesday that it will not bring proceedings against Novartis in connection with the payments the Swiss pharmaceutical company made to Donald Trump’s personal lawyer. The OAGexternal link had received a criminal complaint...

Greece's government says it has evidence that senior politicians from the previous administration were involved in a bribery case in which Swiss drugmaker Novartis is accused of making illegal payments to fix prices and increase market access (Keystone) - Click to enlarge Switzerland’s Federal Office of Justice has confirmed it has received two requests for legal assistance from Greece and the United States...

The so-called Schweizerhalle, a Novartis factory in Muttenz (© KEYSTONE / GEORGIOS KEFALAS) - Click to enlarge Greece’s parliament has linked ten prominent politicians to a bribery scandal involving Swiss drug-maker Novartis. The Greek parliament announced on Tuesday the results of a judicial investigation into alleged bribes paid to public officials by Basel-based Novartisexternal link over nearly a decade...

Investec Switzerland. Novartis AG said profit may fall this year as the Swiss drugmaker increases spending on the heart medicine Entresto and faces declining sales of its best-selling cancer treatment Gleevec. © Lucaderoma | Dreamstime.com Core operating income will either be about the same as 2015 or decline by a percentage in the low single digits at constant exchange rates, Novartis said Tuesday in a statement. Sales will show little change. Novartis is depending on...

Investec Switzerland. Novartis AG said profit may fall this year as the Swiss drugmaker increases spending on the heart medicine Entresto and faces declining sales of its best-selling cancer treatment Gleevec. © Lucaderoma | Dreamstime.com Core operating income will either be about the same as 2015 or decline by a percentage in the low single digits at constant exchange rates, Novartis said Tuesday...

Investec Switzerland. Reuters reports that an investigation is taking place after an anonymous whistle-blower accused Novartis of paying bribes through a consulting firm to secure business advantages in Turkey worth around $85 million, citing an email seen by a reporter. © Roger Heil | Dreamstime.com The benefits are reported to include getting medicines added to lists of drugs approved for prescription in government-run hospitals and avoiding price cuts. Novartis says it...

Investec Switzerland. The SMI is set to end the week modestly lower along with global stocks after earnings reports from pharmaceuticals heavyweights Roche and Novartis fell short of analyst’s estimates. Global markets experienced another volatile week amid ongoing speculation over whether central banks will come to the rescue of turbulent financial markets. A bad week for Novartis – © Lucaderoma | Dreamstime.com The slowdown in China and central remained central to...

Investec Switzerland. The soaring cost of some medicines has sparked a controversy that’s hampered drugmakers’ ability to raise prices in their biggest and most profitable market. © Robert Byron | Dreamstime.com Novartis AG Chief Executive Officer Joe Jimenez figures the golden days of unfettered price increases are over in the U.S. “Those days are over,” Jimenez said in a Bloomberg Television interview with Manus Cranny. “You have to assume that there is going to be...